Status:

UNKNOWN

Patient Experiences Following Urinary Diversion as Part of Surgery for Advanced and Recurrent Rectal Cancer

Lead Sponsor:

St Vincent's University Hospital, Ireland

Conditions:

Patient Satisfaction

Quality of Life

Eligibility:

All Genders

18+ years

Brief Summary

The outcomes of patients who undergo radical surgery for locally advanced and recurrent rectal cancer have improved vastly, but there is a lack of emphasis on the quality-of-life outcomes of these pat...

Detailed Description

Considerable progress has been made in the management of advanced and recurrent pelvic cancer over the last few decades. However, much emphasis has been placed on surgical and hospital-related outcome...

Eligibility Criteria

Inclusion

  • Histologically-proven advanced rectal cancer
  • Has undergone urinary diversion/reconstruction
  • Aged 18 years or older
  • Able and willing to give written, informed consent
  • Able to access email/internet

Exclusion

  • Strong evidence of metastatic or peritoneal disease
  • Palliative exenteration
  • Non-rectal origin of primary tumour
  • Colonic obstruction
  • Inability to answer online questionnaire

Key Trial Info

Start Date :

December 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2022

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT04715308

Start Date

December 1 2020

End Date

March 1 2022

Last Update

February 10 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Vincent's Hospital

Dublin, Ireland, D4